In the ever-evolving field of diabetes management, glucagon-like peptide-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent https://marvinywol787739.targetblogs.com/39482137/the-emerging-landscape-of-glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide